1. Home
  2. MVBF vs ALT Comparison

MVBF vs ALT Comparison

Compare MVBF & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVBF
  • ALT
  • Stock Information
  • Founded
  • MVBF 1997
  • ALT 1997
  • Country
  • MVBF United States
  • ALT United States
  • Employees
  • MVBF N/A
  • ALT N/A
  • Industry
  • MVBF Major Banks
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MVBF Finance
  • ALT Health Care
  • Exchange
  • MVBF Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MVBF 333.7M
  • ALT 333.6M
  • IPO Year
  • MVBF N/A
  • ALT N/A
  • Fundamental
  • Price
  • MVBF $26.80
  • ALT $3.93
  • Analyst Decision
  • MVBF Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • MVBF 5
  • ALT 6
  • Target Price
  • MVBF $26.60
  • ALT $17.40
  • AVG Volume (30 Days)
  • MVBF 35.8K
  • ALT 3.0M
  • Earning Date
  • MVBF 10-29-2025
  • ALT 11-11-2025
  • Dividend Yield
  • MVBF 2.53%
  • ALT N/A
  • EPS Growth
  • MVBF N/A
  • ALT N/A
  • EPS
  • MVBF 1.29
  • ALT N/A
  • Revenue
  • MVBF $143,378,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MVBF N/A
  • ALT N/A
  • Revenue Next Year
  • MVBF $14.93
  • ALT N/A
  • P/E Ratio
  • MVBF $20.83
  • ALT N/A
  • Revenue Growth
  • MVBF N/A
  • ALT N/A
  • 52 Week Low
  • MVBF $15.59
  • ALT $2.90
  • 52 Week High
  • MVBF $27.22
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MVBF N/A
  • ALT 52.80
  • Support Level
  • MVBF N/A
  • ALT $3.85
  • Resistance Level
  • MVBF N/A
  • ALT $4.06
  • Average True Range (ATR)
  • MVBF 0.00
  • ALT 0.20
  • MACD
  • MVBF 0.00
  • ALT 0.02
  • Stochastic Oscillator
  • MVBF 0.00
  • ALT 57.35

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: